Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Dermatology
Vitiligo
Questions discussed in this category
How do you manage new-onset vitiligo in a patient on immune checkpoint inhibitors?
Do you hold ICI, prescribe steroids, or refer to dermatology, and does your approach vary between curative, adjuvant, or metastatic settings?
3 Answers available
What prescription or over-the-counter therapies have you found effective for helping vitiligo patients cover active areas?
3 Answers available
25575
14256
Papers discussed in this category
The New England journal of medicine, 2022 Oct 20
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.
JAAD case reports, 2024 Nov 26
Topical ruxolitinib for treatment-induced vitiligo in a patient with metastatic melanoma.
MedComm, 2025 Mar 04
Combining JAK Inhibitors with Immune Checkpoint Inhibitors: Overcoming Resistance in Cancer Treatment.
Related Topics in Dermatology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Oncology
Palliation
Gastrointestinal Cancers
Genitourinary Cancers
Melanoma/Skin Cancer